Today: 16 July 2026
Apple (NASDAQ: AAPL) Jumps $254 Billion After China AI Approval
16 July 2026
1 min read

Apple (NASDAQ: AAPL) Jumps $254 Billion After China AI Approval

NEW YORK, July 16, 2026, 14:06 EDT – Apple gained $254 billion in market value after getting approval for its AI products in China.

  • Apple gained 1.4% to $332.13 in Thursday afternoon trading.
  • Its market value rose about $254 billion in two sessions.
  • China registered Apple Intelligence but gave no launch date.

Apple’s two-session rally increased its market value by about $254 billion by Thursday afternoon. The stock gained 1.4% after Wednesday’s 4% record close.

Since Tuesday’s close, Apple has risen 5.5%. The value gain is nearly four times fiscal-2025 Greater China sales.

That ratio is the investor signal. It suggests markets expect a multiyear ecosystem boost, not just one strong quarter.

China’s cyberspace regulator registered Apple Intelligence for domestic iPhones on Wednesday. Registration is required before release. No launch date was given.

Alibaba Group Holding (NYSE: BABA) said Qwen will connect with Apple Intelligence. Baidu (NASDAQ: BIDU) confirmed it is working on local features.

The shipment background improved before any AI rollout. Apple’s China volumes rose 24.4% in the June quarter, IDC said. The wider market fell 4.3%.

“Huawei and Apple kept their prices steady while competitors raised theirs,” IDC analyst Arthur Guo said. Apple had 18.1% of shipments, behind Huawei’s 22.6%. Reuters

That distinction matters. The rebound was driven by prices, not AI. China approval first protects Apple’s competitive position. Growth must still follow.

The stock now has the highest trailing multiple among these peers.

SecurityPriceThursday moveTrailing P/EMarket cap
Apple (NASDAQ: AAPL)$332.13up 1.4%40.2x$4.89tn
Microsoft (NASDAQ: MSFT)$402.76up 1.8%24.0x$3.00tn
Alphabet (NASDAQ: GOOGL)$371.66up 0.2%28.3x$4.50tn
Invesco QQQ Trust (NASDAQ: QQQ)$706.89down 1.5%

Prices at 13:50 EDT. Figures are rounded.

Apple’s multiple stands 42% above Alphabet’s and 68% above Microsoft’s. QQQ’s 1.5% decline shows the divergence.

Morgan Stanley (NYSE: MS) analyst Erik Woodring said approval is a catalyst that “should level the AI playing field in China.” The bank kept its Overweight rating and $360 target. TipRanks

A more cautious view surfaced Tuesday. KeyBanc analyst Brandon Nispel cut Apple to Underweight, keeping a $250 target. He cited slower iPhone sales and slower upgrades.

Apple’s July 30 results are the next test. Investors will look for China revenue, rollout timing and margin details.

Risks remain concentrated. China’s approval does not include a launch date. Recent shipment growth relied partly on steady pricing. A weak rollout or margin miss could compress Apple’s premium.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • SK Hynix Shares Seen as Bargain Despite Turbulent Trading
    July 16, 2026, 4:36 PM EDT. SK Hynix (KOSE:A000660) has recorded an impressive 586.3% return in the past year and has multiplied roughly 15-fold over five years. While the stock has experienced notable declines recently, valuation checks from Simply Wall St indicate that it remains undervalued, meeting 5 out of 6 criteria. Its current price-to-earnings (P/E) ratio stands at about 17.9x, which is lower than the semiconductor industry average of 20.4x and well under peer levels averaging 58.8x. Simply Wall St's fair value estimate for SK Hynix is a P/E of 84.2x, pointing to considerable upside if the firm's growth and earnings projections are realized. However, the recent price swings underscore how investor sentiment can quickly shift, particularly as developments around AI memory technology and access to the U.S. market continue to unfold.
Health stocks today: Abbott (NYSE: ABT) jumps 11% as insurers split
Previous Story

Health stocks today: Abbott (NYSE: ABT) jumps 11% as insurers split

Microsoft (NASDAQ: MSFT) Stock Rallies Against Nasdaq Slide Despite AI Spending Discount
Next Story

Microsoft (NASDAQ: MSFT) Stock Rallies Against Nasdaq Slide Despite AI Spending Discount

Go toTop